Search research articles
Contact Us
Filters
Showing results (21-30 of 129) with videos related to
Page
of 13
Sort By:
Journal of Gastroenterology and Hepatology
|
April 17, 2009
Will non-invasive markers replace liver biopsy for diagnosing and staging fibrosis in non-alcoholic steatohepatitis?
Etsuko Hashimoto, Geoffrey C Farrell
Journal of Gastroenterology and Hepatology
|
August 26, 2009
Clues from the carotids: an appraisal of cardiovascular disease risk in non-alcoholic fatty liver disease
Shivakumar Chitturi, Geoffrey C Farrell
Clinics in Liver Disease
|
July 26, 2003
Hepatotoxicity associated with non-steroidal anti-inflammatory drugs
Narci C Teoh, Geoffrey C Farrell
Expert Opinion on Drug Safety
|
August 9, 2003
Drug-induced cholestasis
Lakshumanan S Velayudham, Geoffrey C Farrell
Journal of Gastroenterology and Hepatology
|
July 16, 2003
Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection
Narci C Teoh, Geoffrey C Farrell
Journal of Gastroenterology and Hepatology
|
September 17, 2003
Clear messages from sonographic shadows? Links between metabolic disorders and liver disease, and what to do about them
Jason M Hui, Geoffrey C Farrell
Journal of Gastroenterology and Hepatology
|
March 6, 2008
Publications from China: the sleeping giant awakens
Khean-Lee Goh, Geoffrey C Farrell
Journal of Gastroenterology and Hepatology
|
June 21, 2008
VAT fat is bad for the liver, SAT fat is not!
Jian-Gao Fan, Geoffrey C Farrell
Journal of Hepatology
|
November 19, 2008
Epidemiology of non-alcoholic fatty liver disease in China
Jian-Gao Fan, Geoffrey C Farrell
Journal of Gastroenterology and Hepatology
|
July 5, 2007
Emerging leaders of gastroenterology and hepatology in the Asia-Pacific region
Geoffrey C Farrell, Neville D Yeomans
Page
of 13
Search research articles
Search
Showing results (21-30 of 129) with videos related to
Sort By:
Page
of 13
Journal of Gastroenterology and Hepatology
|
April 17, 2009
Will non-invasive markers replace liver biopsy for diagnosing and staging fibrosis in non-alcoholic steatohepatitis?
Etsuko Hashimoto, Geoffrey C Farrell
Journal of Gastroenterology and Hepatology
|
August 26, 2009
Clues from the carotids: an appraisal of cardiovascular disease risk in non-alcoholic fatty liver disease
Shivakumar Chitturi, Geoffrey C Farrell
Clinics in Liver Disease
|
July 26, 2003
Hepatotoxicity associated with non-steroidal anti-inflammatory drugs
Narci C Teoh, Geoffrey C Farrell
Expert Opinion on Drug Safety
|
August 9, 2003
Drug-induced cholestasis
Lakshumanan S Velayudham, Geoffrey C Farrell
Journal of Gastroenterology and Hepatology
|
July 16, 2003
Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection
Narci C Teoh, Geoffrey C Farrell
Journal of Gastroenterology and Hepatology
|
September 17, 2003
Clear messages from sonographic shadows? Links between metabolic disorders and liver disease, and what to do about them
Jason M Hui, Geoffrey C Farrell
Journal of Gastroenterology and Hepatology
|
March 6, 2008
Publications from China: the sleeping giant awakens
Khean-Lee Goh, Geoffrey C Farrell
Journal of Gastroenterology and Hepatology
|
June 21, 2008
VAT fat is bad for the liver, SAT fat is not!
Jian-Gao Fan, Geoffrey C Farrell
Journal of Hepatology
|
November 19, 2008
Epidemiology of non-alcoholic fatty liver disease in China
Jian-Gao Fan, Geoffrey C Farrell
Journal of Gastroenterology and Hepatology
|
July 5, 2007
Emerging leaders of gastroenterology and hepatology in the Asia-Pacific region
Geoffrey C Farrell, Neville D Yeomans
Page
of 13